High Accuracy Nanopore Sequencing
高精度纳米孔测序
基本信息
- 批准号:9980937
- 负责人:
- 金额:$ 69.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAdoptionBackClinicalDNADNA sequencingDataData AnalysesDevelopmentDevicesElectrodesElectrolytesEngineeringEnzymesEpigenetic ProcessFundingGenomic DNAGeometryGoalsHealthcareHumanHybridsIndustrializationIndustryIon Channel GatingIonsKineticsLifeLongevityMedicalMedical ResearchMethodsMiniaturizationModificationMolecular MotorsMotionMotivationNational Human Genome Research InstituteNatural regenerationNoiseNucleotidesOxidation-ReductionPlayPrincipal InvestigatorProcessReadingReagentResearchResolutionRoleRunningSamplingScienceSignal TransductionSpeedSystemTechniquesTechnologyVariantWorkbaseclinical applicationdata reductiondensityexperimental studyhelicaseimprovedinsightinstrumentmutantnanoporeparallelizationprogramssingle moleculesuccesstechnology validationtoolvoltage
项目摘要
Principal Investigator/Program director (Last, first, middle): Gundlach, Jens, H.
High Accuracy Nanopore Sequencing
PROJECT SUMMARY
The objective of this proposal is to enable nanopore sequencing technology to reach its fullest
potential. With NHGRI funding, our group has played a pivotal role in developing nanopore
sequencing. We paved the way to nanopore sequencing by first engineering the highly sensitive pore
MspA to provide single-nucleotide resolution and then by controlling the DNA speed through MspA
with an enzyme to give the first proof of concept of nanopore sequencing. In this application we
outline techniques that will overcome the last hurdle to nanopore sequencing, low base calling
accuracy.
We request funding through this application to increase the single-passage base calling accuracy of
nanopore sequencing by more than an order of magnitude to better than 99%. This goal is a
transformative step forward for nanopore sequencing since it opens up ubiquitous applications of
this technology in health care and beyond. Additionally, we will explore other improvements and
variations that make nanopore sequencing less expensive and more useful.
Our specific aims are: (1) implementing a hybrid-voltage-enzyme control of DNA that dithers DNA
back and forth, thereby allowing identification and correction of enzyme error modes, while
maximizing the information obtainable from the ion current readings, (2) improving the fundamental
components of the nanopore sequencer by (i) improving the pore used for sequencing and (ii)
teaming up with helicase experts to develop DNA-controlling enzymes specifically engineered to
optimize nanopore sequencing quality, (3) developing techniques that permit high integration density
of nanopores to increase sequencing throughput and to minimize DNA input quantity.
Our team's success to date has enabled us to form partnerships with prominent collaborators and
to gain support from many excellent labs in academia and industry, whose expertise assists us in
bringing nanopore sequencing into health care. We will work with our partner labs to complete the
aims outlined in this proposal.
It is our goal to improve the quality of human life by delivering revolutionary sequencing technology
that is accurate, fast and inexpensive.
Project Summary
首席调查员/项目主任(最后、第一、中间):Gundlach、Jens、H.
高精度纳米孔测序
项目总结
这项提议的目标是使纳米孔测序技术达到最大限度
潜力。在NHGRI的资助下,我们的团队在开发纳米孔方面发挥了关键作用
测序。我们首先设计了高度敏感的孔,为纳米孔测序铺平了道路。
MSPA提供单核苷酸拆分,然后通过MSPA控制DNA速度
用一种酶给出了纳米孔测序概念的第一个证据。在此应用程序中,我们
概述将克服纳米孔测序的最后障碍的技术,低碱基调用
精确度。
我们通过此应用程序申请资金,以提高单通道基本呼叫的准确性
纳米孔测序要好于99%以上一个数量级。这个目标是一个
纳米孔测序向前迈出了革命性的一步,因为它开启了无处不在的应用
这项技术在医疗保健和其他领域都是如此。此外,我们还将探索其他改进措施和
使纳米孔测序成本更低、更有用的变化。
我们的具体目标是:(1)实现DNA的混合电压酶控制,使DNA抖动
从而允许识别和纠正酶错误模式,同时
最大化从离子电流读数中获得的信息,(2)改善基本
通过(I)改善用于测序的孔和(Ii)
与解旋酶专家合作开发DNA控制酶,专门设计成
优化纳米孔测序质量,(3)开发允许高集成密度的技术
使用纳米孔来增加测序吞吐量,并将DNA输入量降至最低。
我们团队到目前为止的成功使我们能够与著名的合作者和
得到学术界和工业界众多优秀实验室的支持,他们的专业知识帮助我们
将纳米孔测序带入医疗保健领域。我们将与合作伙伴实验室合作完成
本提案中概述的目标。
我们的目标是通过提供革命性的测序技术来提高人类的生活质量
这是准确、快速和廉价的。
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JENS GUNDLACH其他文献
JENS GUNDLACH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JENS GUNDLACH', 18)}}的其他基金
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 69.76万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 69.76万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 69.76万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 69.76万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 69.76万 - 项目类别:
Standard Grant